Improving hepatitis C direct-acting antiviral access and uptake: A role for patient-reported outcomes and lived experience
Hepatitis C virus contributes to substantial and growing mortality and morbidity. Fortunately, the advent of highly effective interferon-free direct-acting antiviral (DAA) medications and new diagnostic tests has the potential to dramatically alter the epidemiologic trajectory of hepatitis C, partic...
| Main Authors: | , , , |
|---|---|
| Format: | Journal Article |
| Published: |
Wiley-Blackwell Publishing Ltd.
2019
|
| Online Access: | http://hdl.handle.net/20.500.11937/74146 |